Torii Pharmaceutical

4551.TTSE PRIME

Key numbers · FY ended 2024-12

Revenue¥60.4bn+10.6% YoY Operating income¥6.8bn+35.0% YoY Total assets¥140.7bn+5.4% YoY EPS (basic)¥179.38+22.4% YoY

Full financial history and reports →

Stock price4551 · View chart ↗

Open the price chart on TradingView.

Latest filings

Mon, Sep 1 · JST1 filing

13:23MATERIALTorii Pharmaceutical · Change in major shareholder

Fri, Jul 4 · JST1 filing

15:265% STAKETorii Pharmaceutical · Nomura Asset Management Co., Ltd. + 2 joint holders · 5.20% → 2.09%−3.11pp

Thu, Jun 19 · JST3 filings

16:385% STAKETorii Pharmaceutical · JAPAN TOBACCO INC. + 1 joint holder · 53.47% → 91.58%+38.11pp 13:405% STAKETorii Pharmaceutical · Shionogi & Co., Ltd. + 1 joint holder · 91.58%new 91.58%09:04MATERIALTorii Pharmaceutical · Change in major shareholder

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
JAPAN TOBACCO INC.	53.47%	0.00pp	2025-06-19
Shionogi & Co., Ltd.joint holder	38.11%	0.00pp	2025-06-19

Each holder's own ratio from its most recent large-shareholding report.